Tag:
PCI-32765
Latest Headlines
Latest Headlines
Pharmacyclics impresses (again) with improved leukemia data on blockbuster hopeful
Anyone looking for a solid reason why J&J's Janssen would pay $150 million upfront to partner on Pharmacyclics' experimental blood cancer drug need look no further than the leukemia data the
Updated: J&J locks in blood cancer compound in $975M pact
A unit of Johnson & Johnson ( $JNJ ) has made big bet on the future of developer Pharmacyclics' ( $PCYC ) experimental compound in midstage testing for blood cancers, shelling out $150 million in
